Cited by 357Cancer-related Molecular PathwaysProtein Kinase Regulation and GTPase SignalingCell death mechanisms and regulation

The DOI matches its Crossref record; 69 of the 75 references it cites were found in a registry or an index.

Opposing Effects of Ras on p53

Open access

Ries, Stefan, Biederer, Carola, Woods, Douglas, Shifman, Ohad, Shirasawa, Senji, Sasazuki, Takehiko, McMahon, Martin, Oren, Moshe, McCormick, Frank·2000·Cell

DOI 10.1016/s0092-8674(00)00123-9

Open this paper in CoChat — free account Open PDF

Abstract

Mdm2 acts as a major regulator of the tumor suppressor p53 by targeting its destruction. Here, we show that the mdm2 gene is also regulated by the Ras-driven Raf/MEK/MAP kinase pathway, in a p53-independent manner. Mdm2 induced by activated Raf degrades p53 in the absence of the Mdm2 inhibitor p19ARF. This regulatory pathway accounts for the observation that cells transformed by oncogenic Ras are more resistant to p53-dependent apoptosis following exposure to DNA damage. Activation of the Ras-induced Raf/MEK/MAP kinase may therefore play a key role in suppressing p53 during tumor development and treatment. In primary cells, Raf also activates the Mdm2 inhibitor p19ARF. Levels of p53 are therefore determined by opposing effects of Raf-induced p19ARF and Mdm2.

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)00123-9

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Self-citation
The p53 tumour suppressor gene
Levine, A. J., Momand, J. A., & Finlay, C. A. (1991) · Nature · doi:10.1038/351453a0 · Cited by 3,785
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751

Show all 75 references

Research works printed but not linked: 1

Bos, 1989, ras oncogenes in human cancer, Cancer Res., 49, 4682

Sorted by citations

Items 201–300 of 356

Mdm2 links genotoxic stress and metabolism to p53
Wang, Z., & Li, B. (2010) · Protein & Cell · doi:10.1007/s13238-010-0140-9 · Cited by 30
Down-regulation of Cdx2 in colorectal carcinoma cells by the Raf–MEK–ERK 1/2 pathway
Krueger, F., Madeja, Z. E., Hemberger, M., McMahon, M., Cook, S. J., & Gaunt, S. J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.07.020 · Cited by 29
Self-citation
Chelidonine Induces Apoptosis via GADD45a-p53 Regulation in Human Pancreatic Cancer Cells
Jang, H., Yang, J., Hong, E., Jo, E., Lee, S., Lee, S., Choi, J. S., Yoo, H., & Kang, H. (2021) · Integrative Cancer Therapies · doi:10.1177/15347354211006191 · Cited by 28
Ha-rasval12 induces HSP70b transcription via the HSE/HSF1 system, but HSP70b expression is suppressed in Ha-rasval12-transformed cells
Stanhill, A., Levin, V., Hendel, A., Shachar, I., Kazanov, D., Arber, N., Kaminski, N., & Engelberg, D. (2005) · Oncogene · doi:10.1038/sj.onc.1209193 · Cited by 29
H-RAS V12–induced radioresistance in HCT116 colon carcinoma cells is heregulin dependent
Carón, R. W., Yacoub, A., Zhu, X., Mitchell, C., Han, S. I., Sasazuki, T., Shirasawa, S., Hagan, M. P., Grant, S., & Dent, P. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.243.4.2 · Cited by 28
Self-citation
Modeling the response of a tumor-suppressive network to mitogenic and oncogenic signals
Tian, X., Huang, B. Y., Zhang, X., Lu, M., Liu, F., Onuchic, J. N., & Wang, W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702412114 · Cited by 28
New druggable targets in the Ras pathway?
Matallanas, D., & Crespo, P. (2010) · PubMed · Cited by 28
Genetic Modeling of Glioma Formation in Mice
Begemann, M., Fuller, G. N., & Holland, E. C. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00428.x · Cited by 28
Transgenic Expression of the p16 INK4a Cyclin-Dependent Kinase Inhibitor Leads to Enhanced Apoptosis and Differentiation Arrest of CD4−CD8− Immature Thymocytes
Lagresle, C., Gardie, B., Eyquem, S., Fasseu, M., Vieville, J.-C., Pla, M., Sigaux, F., & Bories, J.-C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2325 · Cited by 28
Hepatitis B virus X antigen (HBxAg) and cell cycle control in chronic infection and hepatocarcinogenesis
Mark, A. F. (2005) · Frontiers in bioscience · doi:10.2741/1640 · Cited by 27
Ral GTPase Down-regulation Stabilizes and Reactivates p53 to Inhibit Malignant Transformation
Tecleab, A., Zhang, X., & Sebti, S. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.565796 · Cited by 27
Immunohistochemical Expression of Mdm2 and p53 in Canine Cutaneous Mast Cell Tumours
Wu, H., Hayashi, T., & Inoue, M. (2006) · Zentralblatt für Veterinärmedizin Reihe A · doi:10.1111/j.1439-0442.2006.00795.x · Cited by 27
Vitamin D directly regulates Mdm2 gene expression in osteoblasts
Chen, H., Reed, G. E., Guardia, J., Lakhan, S., Couture, O. P., Hays, E., & Chandar, N. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.003 · Cited by 27
Cellular lifespan and senescence: a complex balance between multiple cellular pathways
Dolivo, D., Hernandez, S. J., & Dominko, T. (2016) · BioEssays · doi:10.1002/bies.201670906 · Cited by 29
Ubiquitin‐immunoreactive degradation products of cytokeratin 8/18 correlate with aggressive breast cancer
Iwaya, K., Ogawa, H., Mukai, Y., Iwamatsu, A., & Mukai, K. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01368.x · Cited by 27
Association of MDM2 SNP309 and TP53 Arg72Pro polymorphisms with risk of endometrial cancer
Yoneda, T., Kuboyama, A., Kato, K., Ohgami, T., Okamoto, K., Saito, T., & Wake, N. (2013) · Oncology Reports · doi:10.3892/or.2013.2433 · Cited by 26
MdmX Is Required for p53 Interaction with and Full Induction of the Mdm2 Promoter after Cellular Stress
Biderman, L., Poyurovsky, M. V., Assia, Y., Manley, J. L., & Prives, C. L. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06150-11 · Cited by 27
Combined inhibition of extracellular signal-regulated kinases and HSP90 sensitizes human colon carcinoma cells to ionizing radiation
Kobayashi, S., Nantz, R., Kitamura, T., Higashikubo, R., & Horikoshi, N. (2005) · Oncogene · doi:10.1038/sj.onc.1208508 · Cited by 26
Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa
de Bruijn, M. T., Raats, D., Hoogwater, F. J. H., van Houdt, W. J., Cameron, K., Medema, J. P., Rinkes, I. H. M. B., & Kranenburg, O. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605633 · Cited by 26
Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis
Tozluoǧlu, M., Karaca, E., Haliloǧlu, T., & Nussinov, R. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn481 · Cited by 26
Regulation of Expression of the Rat Orthologue of Mouse Double Minute 2 (MDM2) by H2O2-induced Oxidative Stress in Neonatal Rat Cardiac Myocytes
Pikkarainen, S., Kennedy, R., Marshall, A. K., Tham, E. L., Lay, K., Kriz, T. A., Handa, B. S., Clerk, A., & Sugden, P. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.037887 · Cited by 26
MCT-1 oncogene downregulates p53 and destabilizes genome structure in the response to DNA double-strand damage
Hsu, H.-L., Choy, C. O., Kasiappan, R., Shih, H.-J., Sawyer, J. R., Shu, C.-L., Chu, K.-L., Chen, Y., Hsu, H.-F., & Gartenhaus, R. B. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.02.028 · Cited by 26
Functional Parsing of Driver Mutations in the Colorectal Cancer Genome Reveals Numerous Suppressors of Anchorage-Independent Growth
Eskiocak, U., Kim, S. B., Ly, P., Roig, A. I., Biglione, S., Komurov, K., Cornelius, C., Wright, W. E., White, M. A., & Shay, J. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0794 · Cited by 26
Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells
Sui, X., Shin, S., Zhang, R., Firozi, P. F., Yang, L., Abbruzzese, J. L., & Reddy, S. A. G. (2009) · Oncogene · doi:10.1038/onc.2008.423 · Cited by 25
Transcriptional and signalling regulation of skin epithelial stem cells in homeostasis, wounds and cancer
Guan, Y., Yang, Y. J., Nagarajan, P., & Ge, Y. (2020) · Experimental Dermatology · doi:10.1111/exd.14247 · Cited by 27
Oxaliplatin-Induced Senescence in Colorectal Cancer Cells Depends on p14ARF-Mediated Sustained p53 Activation
Tomicic, M. T., Krämer, F., Nguyen, A., Schwarzenbach, C., & Christmann, M. (2021) · Cancers · doi:10.3390/cancers13092019 · Cited by 28
Downregulation of extracellular signal-regulated kinase 1/2 activity by calmodulin KII modulates p21Cip1 levels and survival of immortalized lymphocytes from Alzheimer’s disease patients
Esteras, N., Alquézar, C., Bermejo-Pareja, F., Bialopiotrowicz, E., Wojda, U., & Martín-Requero, Á. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.014 · Cited by 25
3-Morpholinosydnonimine Hydrochloride Induces p53-Dependent Apoptosis in Murine Primary Neural Cells: A Critical Role for p21ras–MAPK–p19ARF Pathway
Kaji, T., Kaieda, I., Hisatsune, T., & Kaminogawa, S. (2002) · Nitric Oxide · doi:10.1006/niox.2001.0389 · Cited by 25
PD98059 triggers G1 arrest and apoptosis in human leukemic U937 cells through downregulation of Akt signal pathway
Moon, D., Park, C., Heo, M., Park, Y., Choi, Y. H., & Kim, G. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.08.009 · Cited by 24
Mdm2 protein Expression is Strongly Associated with Survival in Malignant Pleural Mesothelioma
Mairinger, F. D., Walter, R. F. H., Ting, S. C., Vollbrecht, C., Kollmeier, J., Griff, S., Hager, T., Mairinger, T., Christoph, D. C., Theegarten, D., et al. (2014) · Future Oncology · doi:10.2217/fon.13.261 · Cited by 26
A p53-JAK-STAT connection involved in myeloproliferative neoplasm pathogenesis and progression to secondary acute myeloid leukemia
Goyal, H., Chachoua, I., Pecquet, C., Vainchenker, W., & Constantinescu, S. N. (2020) · Blood Reviews · doi:10.1016/j.blre.2020.100712 · Cited by 24
Crosstalk Between Vitamin D and p53 Signaling in Cancer: An Update
Reichrath, J., Reichrath, S., VOGT, T. M., & Römer, K. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-46227-7_15 · Cited by 23
Molecular targets for altering radiosensitivity: Lessons from Ras as a pre-clinical and clinical model
Cengel, K. A., & McKenna, W. G. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.02.001 · Cited by 23
Ras mutation promotes p53 activation and apoptosis of skin keratinocytes
Zhao, Y. (2005) · Carcinogenesis · doi:10.1093/carcin/bgl037 · Cited by 22
Regions and Activities of Simian Virus 40 T Antigen That Cooperate with an Activated ras Oncogene in Transforming Primary Rat Embryo Fibroblasts
Beachy, T. M., Cole, S., Cavender, J. F., & Tevethia, M. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.7.3145-3157.2002 · Cited by 22
Oncogenic RAS sensitizes cells to drug-induced replication stress via transcriptional silencing of P53
Segeren, H. A., van Liere, E. A., Riemers, F. M., de Bruin, A., & Westendorp, B. (2022) · Oncogene · doi:10.1038/s41388-022-02291-0 · Cited by 21
Significance of MDM2 and P14ARF polymorphisms in susceptibility to differentiated thyroid carcinoma
Zhang, F., Xu, L., Wei, Q., Song, X., Sturgis, E. M., & Li, G. (2012) · Surgery · doi:10.1016/j.surg.2012.11.009 · Cited by 21
Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene
Liang, H., & Lunec, J. (2005) · Gene · doi:10.1016/j.gene.2005.07.018 · Cited by 21
Contribution of Murine Double Minute 2 Genotypes to Colorectal Cancer Risk in Taiwan
YUEH, T.-C., Hung, Y.-W., Shih, T., Wu, C.-N., WANG, S.-C., Lai, Y.-L., Hsu, S.-W., WU, M.-H., Fu, C.-K., WANG, Y.-C., et al. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20099 · Cited by 20
TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis
Shai, A., Dankort, D. L., Juan, J. M., Green, S., & McMahon, M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3701 · Cited by 20
Self-citation
p53-Mediated Oxidative Stress Enhances Indirubin-3′-Monoxime-Induced Apoptosis in HCT116 Colon Cancer Cells by Upregulating Death Receptor 5 and TNF-Related Apoptosis-Inducing Ligand Expression
Dilshara, M. G., Molagoda, I. M. N., Jayasooriya, R. G. P. T., Choi, Y. H., Park, C., Lee, K. T., Lee, S., & Kim, G. (2019) · Antioxidants · doi:10.3390/antiox8100423 · Cited by 19
The p53-HDM2 gene-gene polymorphism interaction is associated with the development of missed abortion
Fang, Y., Kong, B., Yang, Q., Ma, D., & Qu, X. (2011) · Human Reproduction · doi:10.1093/humrep/der017 · Cited by 20
The p53 Tumor Suppressor Pathway and Cancer
Zambetti, G. P. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5 · Cited by 20
Testosterone modulates FoxO3a and p53-related genes to protect C2C12 skeletal muscle cells against apoptosis
Pronsato, L., Milanesi, L. M., Vasconsuelo, A., & la Colla, A. B. (2017) · Steroids · doi:10.1016/j.steroids.2017.05.012 · Cited by 20
Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence
Schmid, G., Kramer, M. P., Maurer‐Granofszky, M., Wandl, S., & Węsierska‐Gądek, J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21383 · Cited by 20
Identification of functional DNA variants in the constitutive promoter region of MDM2
Lalonde, M., Ouimet, M., Larivière, M., Kritikou, E. A., & Sinnett, D. (2012) · Human Genomics · doi:10.1186/1479-7364-6-15 · Cited by 19
Targeting K-Ras and apoptosis-driven cellular transformation in cancer
Godwin, I., Anto, N. P., Bava, S. V., Babu, M. S., & Jinesh, G. G. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00457-5 · Cited by 19
MDM2 SNP309 polymorphism is associated with colorectal cancer risk
Wang, W., Du, M., Gu, D., Zhu, L., Chu, H., Tong, N., Zhang, Z., Xu, Z., & Wang, M. (2014) · Scientific Reports · doi:10.1038/srep04851 · Cited by 19
Sprouty 2 Regulates DNA Damage-induced Apoptosis in Ras-transformed Human Fibroblasts
Lito, P., Mets, B. D., Appledorn, D. M., Maher, V. M., & McCormick, J. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808045200 · Cited by 19
Studies on modulation of the activity of tumor suppressor protein p53
Kadaja, L. (2004) · DSpace repository (University of Tartu) · Cited by 19
Splice Variants of MDM2 in Oncogenesis
Rosso, M., Okoro, D. R., & Bargonetti, J. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_14 · Cited by 18
Regulation of homeostasis and oncogenesis in the intestinal epithelium by Ras
Velho, S., & Haigis, K. M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.06.002 · Cited by 18
Genome-wide association and sequencing studies on colorectal cancer
Wong, S. H., Sung, J. J. �., Chan, F. K. L., To, K. F., Ng, S. S. M., Wang, X., Yu, J. Q., & Wu, W. K. K. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.09.005 · Cited by 18
The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma
Karsy, M. J., Albert, L., Murali, R., & Jhanwar‐Uniyal, M. (2014) · Tumor Biology · doi:10.1007/s13277-013-1601-6 · Cited by 17
p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours
Dimitriadi, M., Poulogiannis, G., Liu, L., Bäcklund, L. M., Pearson, D. M., Ichimura, K., & Collins, V. P. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604643 · Cited by 17
Modulation of the p53 family network by RNA-binding proteins
Lucchesi, C. A., Zhang, J., & Chen, X. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.08.30 · Cited by 17
Low‐dose mithramycin exerts its anticancer effect via the p53 signaling pathway and synergizes with nutlin‐3 in gynecologic cancers
Ohgami, T., Kato, K., Kobayashi, H., Sonoda, K., Inoue, T., Yamaguchi, S., Yoneda, T., & Wake, N. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01543.x · Cited by 17
Influence of TP53 Codon 72 Polymorphism Alone or in Combination with HDM2 SNP309 on Human Infertility and IVF Outcome
Chan, Y., Zhu, B., Jiang, H., Zhang, J., Luo, Y., & Tang, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167147 · Cited by 17
Age‐dependent association of MDM2 promoter polymorphisms and uterine leiomyoma in S outh‐ E ast I ran: A preliminary report
Salimi, S., Hajizadeh, A., Khodamian, M., Pejman, A., Fazeli, K., & Yaghmaei, M. (2014) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12625 · Cited by 16
Assessment of functional tag single nucleotide polymorphisms within the DRD2 gene as risk factors for post-traumatic stress disorder in the Han Chinese population
Duan, Z., He, M., Zhang, J., Chen, K., Li, B., & Wang, J. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.066 · Cited by 16
Model of the developing tumorigenic phenotype in mammalian cells and the roles of sustained stress and replicative senescence
Karpinets, T. V., & Foy, B. D. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2003.11.005 · Cited by 15
Oncogenic H-ras induces cyclin B1 expression in a p53-independent manner
Santana, C., Ortega, E., & García-Carrancá, A. M. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00172-0 · Cited by 16
p53 Is Necessary for the Apoptotic Response Mediated by a Transient Increase of Ras Activity
Ma, P., Magut, M., Chen, X., & Chen, C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.2928-2938.2002 · Cited by 16
Monotone Piecewise Affine Systems
Aswani, A. J., & Tomlin, C. J. (2009) · IEEE Transactions on Automatic Control · doi:10.1109/tac.2009.2023771 · Cited by 15
Discrepancies between the K-ras mutational status of primary colorectal cancers and corresponding liver metastases are found in codon 13
Kawamata, H., Yamashita, K., Kojo, K., Ushiku, H., Ooki, A., & Watanabe, M. (2015) · Genomics · doi:10.1016/j.ygeno.2015.05.007 · Cited by 14
Impact of MDM2 polymorphism
Chaar, I., Arfaoui, A. T., Amine, E. H. O. E., Mahmoud, L. K. B., Khiari, M., Sammoud, S., Lounis, M. A., Amara, S., Gharbi, L., Hmida, A. B., et al. (2012) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32834bdf84 · Cited by 14
Increased expression of hras induces early, but not full, senescence in the immortal fish cell line, EPC
Futami, K., Aoyama, K., Fukuda, K., Maita, M., & Katagiri, T. (2020) · Gene · doi:10.1016/j.gene.2020.145116 · Cited by 14
MAP Kinase Pathways in the Control of Hepatocyte Growth, Metabolism and Survival
Dent, P. (2005) · Springer eBooks · doi:10.1007/3-540-27194-5_19 · Cited by 14
Resveratrol modulates gene expression associated with apoptosis, proliferation and cell cycle in cells with mutated human c-Ha-Ras, but does not alter c-Ha-Ras mRNA or protein expression
Young, L. F., Hantz, H. L., & Martin, K. R. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.03.004 · Cited by 14
Ras GTPases: Singing in Tune
Symons, M. H., & Takai, Y. (2001) · Science Signaling · doi:10.1126/stke.2001.68.pe1 · Cited by 16
The mechanisms of regulation of Hdm2 protein level by serum growth factors
Phillips, A., Jones, C. J., & Blaydes, J. P. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.12.026 · Cited by 13
NORE1A Regulates MDM2 Via β-TrCP
Schmidt, M., Calvisi, D. F., & Clark, G. (2016) · Cancers · doi:10.3390/cancers8040039 · Cited by 12
Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons
Tipanee, J., Matteo, M. D., Tulalamba, W., Samara-Kuko, E., Keirsse, J., Ginderachter, J. A. V., Chuah, M., & VandenDriessche, T. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.01.015 · Cited by 11
Genetic and epigenetic alterations in lung tumors from bitransgenic Ki‐rasG12C expressing mice
Floyd, H. S., Jennings‐Gee, J. E., Kock, N. D., & Miller, M. S. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20181 · Cited by 12
Molecular Analysis of Oncogenes, ras Family Genes (N‐ras, K‐ras, H‐ras), myc Family Genes (c‐myc, N‐myc) and mdm2 in Natural Killer Cell Neoplasms
Sugimoto, K., Kawamata, N., Sakajiri, S., & Oshimi, K. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01234.x · Cited by 12
GC-selective DNA-binding antibiotic, Mithramycin A, reveals multiple points of control in the regulation of Hdm2 protein synthesis
Phillips, A., Darley, M., & Blaydes, J. P. (2006) · Oncogene · doi:10.1038/sj.onc.1209451 · Cited by 12
Functional single nucleotide polymorphisms of the RASSF3 gene and susceptibility to squamous cell carcinoma of the head and neck
Guo, H.-G., Liu, H., Wei, J., Li, Y., Yu, H., Guan, X., Li-E, W., Li, G., Sturgis, E. M., Wei, Q., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.11.009 · Cited by 11
TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response
Wu, C., Koay, T. S., Ho, Y.-H., Lovat, P. E., & Lunec, J. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0768-3 · Cited by 11
Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF
Mukherjee, B., Tiwari, A. K., Palo, A., Pattnaik, N., Samantara, S. K., & Dixit, M. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01240-w · Cited by 11
Targeting KRAS-mutant stomach/colorectal tumors by disrupting the ERK2-p53 complex
Wang, X., Xie, Q. M., Ji, Y., Yang, J., Shen, J., Peng, F., Zhang, Y., Jiang, F., Kong, X., Ma, W., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2022.111972 · Cited by 11
Terminal Endbuds and Acini as the Respective Major Targets for Chemical and Sporadic Carcinogenesis in the Mammary Glands of Human c-Ha-ras Protooncogene Transgenic Rats
Hamaguchi, T., Matsuoka, Y., Kawaguchi, H., Fukamachi, K., Takasuka, N., Ueda, S., Shimizu, K., Ohki, M., Kusunoki, M., Sakakura, T., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000010698.09512.d2 · Cited by 11
p14ARF inhibits the growth of p53 deficient cells in a cell-specific manner
Li, Y., He, L., Bruce, A., Parihar, K., Ingram, A. J., Liu, L., & Tang, D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.04.011 · Cited by 11
p53 mitigates the effects of oncogenic HRAS in urothelial cells via the repression of MCOLN1
Jung, J., Liao, H., Coker, S. A., Liang, H., Hancock, J., Denicourt, C., & Venkatachalam, K. (2021) · iScience · doi:10.1016/j.isci.2021.102701 · Cited by 10
Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk
Fu, Q., Zhang, G., Chen, H., Zheng, Y., & Cheng, J. (2013) · Tumor Biology · doi:10.1007/s13277-013-0956-z · Cited by 10
Thiostrepton degrades mutant p53 by eliciting an autophagic response in SW480 cells
Kalathil, D., Prasad, M., Chelladurai, M., John, S., & Nair, S. A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26601 · Cited by 10
Enhanced G1 arrest and apoptosis via MDM4/MDM2 double knockdown and MEK inhibition in wild‑type TP53 colon and gastric cancer cells with aberrant KRAS signaling
Wang, X., Yamamoto, Y., Imanishi, M., Zhang, X., Sato, M., Sugaya, A., Hirose, M., Endo, S., Natori, Y., Moriwaki, T., et al. (2021) · Oncology Letters · doi:10.3892/ol.2021.12819 · Cited by 10
Frequency and prognostic significance of murine double minute protein-2 overexpression and p53 gene mutations in childhood acute lymphoblastic leukemia
Hendy, O. M., Elghannam, D. M., El-Sharnouby, J. A., Goda, E. F., El-Ashry, R. A., & Al-Tonbary, Y. A. (2009) · Hematology · doi:10.1179/102453309x12473408860389 · Cited by 10
Growth stimulation of UV-induced DNA damage retaining epidermal basal cells gives rise to clusters of p53 overexpressing cells
Nijhof, J. G. W., Mulder, A. M., Speksnijder, E. N., Hoogervorst, E. M., Mullenders, L. H. F., & de Gruijl, F. R. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.05.008 · Cited by 10
v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1
MacLaren, A., Clark, W. A., Black, E. J., Gregory, D. J., Fujii, H., & Gillespie, D. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206329 · Cited by 10
Cell signaling and the aging of B cells
Labi, V., & Derudder, E. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.110985 · Cited by 9
Regulation of male germline transmission patterns by the Trp53-Cdkn1a pathway
Kanatsu‐Shinohara, M., Naoki, H., Tanaka, T. S. T., Tatehana, M., Kikkawa, T., Osumi, N., & Shinohara, T. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.07.007 · Cited by 9
Final checkup of neoplastic DNA replication: Evidence for failure in decision-making at the mitotic cell cycle checkpoint G1/S
Prindull, G. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.07.009 · Cited by 9
A cohort study on the association of MDM2 SNP309 with lung cancer risk in Bangladeshi population
Reza, H. A., Anamika, W. J., Chowdhury, M. M. K., Mostafa, M., & Uddin, M. A. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2018.125 · Cited by 11
Loss of DLK expression in WI-38 human diploid fibroblasts induces a senescent-like proliferation arrest
Daviau, A., Couture, J.-P., & Blouin, R. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.086 · Cited by 9
Terpenes
Wiart, C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-398371-8.00002-7 · Cited by 10
Opposite Role of Ras in Tumor Necrosis Factor-α-Induced Cell Cycle Regulation: Competition for Raf Kinase
Park, S.-J., Kim, Y.-Y., Lim, J.-Y., Seo, G., Kim, J., Park, S.-I., & Park, B.-J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5713 · Cited by 9
Computer-aided drug discovery for pathway and genetic diseases
Aswani, A. J., & Tomlin, C. J. (2010) · IEEE Conference on Decision and Control (CDC) · doi:10.1109/cdc.2010.5717302 · Cited by 8
Molecular and Genetic Events in Neoplastic Transformation
Erson-Bensan, A. E., & Petty, E. M. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0004 · Cited by 8
Topology based control of biological genetic networks
Aswani, A. J., & Tomlin, C. J. (2008) · IEEE Conference on Decision and Control (CDC) · doi:10.1109/cdc.2008.4739102 · Cited by 8
Graph-theoretic topological control of biological genetic networks
Aswani, A. J., Boyd, N. R., & Tomlin, C. J. (2009) · Proceedings of the ... American Control Conference/Proceedings of the American Control Conference · doi:10.1109/acc.2009.5160714 · Cited by 8

Authors: Ries, S., Biederer, C., Woods, D., Shifman, O., Shirasawa, S., Sasazuki, T., McMahon, M., Oren, M., & McCormick, F.
Affiliations: University of California, San Francisco (US)
Weizmann Institute of Science (IL)
Kyushu University (JP)
Corresponding author: McCormick, Frank
ORCID: Ries, Stefan
Shifman, Ohad
Shirasawa, Senji
Sasazuki, Takehiko
McMahon, Martin
Oren, Moshe
McCormick, Frank
Venue: Cell
Publisher: Elsevier BV
Published: 2000-10
Volume: 103
Issue: 2
Pages: 321-330
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/s0092-8674(00)00123-9
OpenAlex: W2022614681
Cited by: 357
References: 75
Citations by year: 2026: 1 · 2025: 5 · 2024: 5 · 2023: 2 · 2022: 4 · 2021: 8 · 2020: 10 · 2019: 4 · 2018: 6 · 2017: 5 · 2016: 10 · 2015: 7 · 2014: 16 · 2013: 9 · 2012: 17
FWCI: 13.36
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4672 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: Ras, p53, MDM2, p19ARF, p53 degradation, p53-dependent apoptosis, DNA damage resistance, oncogenic Ras, tumor suppression
MeSH terms: Animals, Base Sequence, Cell Line, Gamma Rays, Mice, Mutant Strains, Molecular Sequence Data, Mutagens, Mutation, Nuclear Proteins, Promoter Regions, Genetic, Proteins, Proto-Oncogene Proteins, Radiation Tolerance, Transcription Factors, Signal Transduction, Tumor Suppressor Protein p53, ras Proteins, Transcription Factor AP-1, Proto-Oncogene Proteins c-raf, Response Elements, Tumor Suppressor Protein p14ARF, Proto-Oncogene Proteins c-ets, Mice, Proto-Oncogene Proteins c-mdm2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Opposing Effects of Ras on p53

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks